BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20445466)

  • 1. Hormone therapy discontinuation: physician practices after the Women's Health Initiative.
    Newton KM; Reed SD; Grothaus LC; La Croix AZ; Nekhlyudov L; Ehrlich K; Ludman EJ
    Menopause; 2010 Jul; 17(4):734-40. PubMed ID: 20445466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-reported changes in providers' hormone therapy prescribing and counseling practices after the Women's Health Initiative.
    Lakey SL; Reed SD; LaCroix AZ; Grothaus L; Newton KM
    J Womens Health (Larchmt); 2010 Dec; 19(12):2175-81. PubMed ID: 21062201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of obstetric practice on workload and practice patterns of family physicians and obstetrician-gynecologists.
    Dresden GM; Baldwin LM; Andrilla CH; Skillman SM; Benedetti TJ
    Ann Fam Med; 2008; 6 Suppl 1(Suppl 1):S5-11. PubMed ID: 18195307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving practice patterns and attitudes toward hormone therapy of obstetrician-gynecologists.
    Power ML; Schulkin J; Rossouw JE
    Menopause; 2007; 14(1):20-8. PubMed ID: 17019376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy.
    Power ML; Zinberg S; Schulkin J
    Menopause; 2006; 13(3):434-41. PubMed ID: 16735940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the WHI study on the attitude of Israeli gynecologists to hormonal therapy during menopause.
    Kaplan B; Yogev Y; Orvieto R; Hirsch M; Fisher M; Rabinerson D
    Clin Exp Obstet Gynecol; 2004; 31(4):267-8. PubMed ID: 15672962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge of clinical trials regarding hormone therapy and likelihood of prescribing hormone therapy.
    Taylor HS; Kagan R; Altomare CJ; Cort S; Bushmakin AG; Abraham L
    Menopause; 2017 Jan; 24(1):27-34. PubMed ID: 27575548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing of FDA-approved and compounded hormone therapy differs by specialty.
    Constantine GD; Archer DF; Graham S; Bernick BA; Mirkin S
    Menopause; 2016 Oct; 23(10):1075-82. PubMed ID: 27648594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician and patient attitudes towards complementary and alternative medicine in obstetrics and gynecology.
    Furlow ML; Patel DA; Sen A; Liu JR
    BMC Complement Altern Med; 2008 Jun; 8():35. PubMed ID: 18582380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of multiple providers for regular care and women's receipt of hormone replacement therapy counseling.
    Gallagher TC; Geling O; Comite F
    Med Care; 2001 Oct; 39(10):1086-96. PubMed ID: 11567171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in the psychosocial determinants of the intention to prescribe hormone therapy prior to the release of the Women's Health Initiative trial: a survey of general practitioners and gynaecologists in France and Quebec.
    Legare F; Godin G; Ringa V; Dodin S; Turcot L; Norton J
    BMC Med Inform Decis Mak; 2005 Sep; 5():31. PubMed ID: 16150149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How the Women's Health Initiative (WHI) influenced physicians' practice and attitudes.
    Bush TM; Bonomi AE; Nekhlyudov L; Ludman EJ; Reed SD; Connelly MT; Grothaus LC; LaCroix AZ; Newton KM
    J Gen Intern Med; 2007 Sep; 22(9):1311-6. PubMed ID: 17634782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specialty differences and the ordering of screening mammography by primary care physicians.
    Taplin SH; Taylor V; Montano D; Chinn R; Urban N
    J Am Board Fam Pract; 1994; 7(5):375-86. PubMed ID: 7810354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes of obstetrician-gynecologists toward the evidence from the Women's Health Initiative hormone therapy trials remain generally skeptical.
    Power ML; Anderson BL; Schulkin J
    Menopause; 2009; 16(3):500-8. PubMed ID: 19169162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Provider attributes associated with hormone therapy prescribing frequency.
    Spangler L; Reed SD; Nekhyludov L; Grothaus LC; LaCroix AZ; Newton KM
    Menopause; 2009; 16(4):810-16. PubMed ID: 19407679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era.
    Nassar AH; Abd Essamad HM; Awwad JT; Khoury NG; Usta IM
    Maturitas; 2005 Sep; 52(1):18-25. PubMed ID: 16143222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and intervention for intimate partner abuse: practices and attitudes of primary care physicians.
    Rodriguez MA; Bauer HM; McLoughlin E; Grumbach K
    JAMA; 1999 Aug; 282(5):468-74. PubMed ID: 10442663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences among primary care physicians' adherence to 2009 ACOG guidelines for cervical cancer screening.
    Corbelli J; Borrero S; Bonnema R; McNamara M; Kraemer K; Rubio D; Karpov I; McNeil M
    J Womens Health (Larchmt); 2014 May; 23(5):397-403. PubMed ID: 24380500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electronic Health Record Adoption among Obstetrician/Gynecologists in the United States: Physician Practices and Satisfaction.
    Raglan GB; Margolis B; Paulus RA; Schulkin J
    J Healthc Qual; 2017; 39(3):144-152. PubMed ID: 28481842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary care physicians' approach to depressive disorders. Effects of physician specialty and practice structure.
    Williams JW; Rost K; Dietrich AJ; Ciotti MC; Zyzanski SJ; Cornell J
    Arch Fam Med; 1999; 8(1):58-67. PubMed ID: 9932074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.